Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-27

Clinical Trial Update: Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study comparing Wockhardt's insulin isophane suspension (30 IU/mL / 70 IU/mL) with Novo Nordisk's Novolin 70/30 in healthy subjects using a glucose cl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVOLIN 70/30 (HUMAN INSULIN)
  • Wockhardt Insulin Isophane Suspension 30 IU/mL / 70 IU/mL (insulin human isophane suspension)

Snippet

Sponsor: Wockhardt | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED